• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Celgene Corporation

Celgene Corporation

  1. All
  2. 3rd Party
  3. Investing
  1. Acceleron to Develop Sotatercept in Pulmonary Arterial Hypertension

    Acceleron to Develop Sotatercept in Pulmonary Arterial Hypertension

  2. Celgene Provides Update on the Fusion™ Clinical Program

    Celgene Provides Update on the Fusion™ Clinical Program

  3. Alvogen Subsidiary Confirms ANDA Filing and Patent Challenge for Generic Revlimid®

    Alvogen Subsidiary Confirms ANDA Filing and Patent Challenge for Generic Revlimid®

12345

©2017 Morningstar Advisor. All right reserved.